Search by Drug Name or NDC

    NDC 67457-0847-44 OGIVRI Details

    OGIVRI

    OGIVRI is a KIT in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Mylan Institutional LLC. The primary component is .

    Product Information

    NDC 67457-0847
    Product ID 67457-847_b57e61b9-04b7-4d8b-b7c2-be56a060421b
    Associated GPIs 21170070302120
    GCN Sequence Number 077982
    GCN Sequence Number Description trastuzumab-dkst VIAL 420 MG INTRAVEN
    HIC3 V1W
    HIC3 Description ANTINEOPLASTIC EGF RECEPTOR BLOCKER MCLON ANTIBODY
    GCN 44158
    HICL Sequence Number 044673
    HICL Sequence Number Description TRASTUZUMAB-DKST
    Brand/Generic Brand
    Proprietary Name OGIVRI
    Proprietary Name Suffix n/a
    Non-Proprietary Name trastuzumab
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form KIT
    Route n/a
    Active Ingredient Strength n/a
    Active Ingredient Units n/a
    Substance Name n/a
    Labeler Name Mylan Institutional LLC
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category BLA
    Application Number BLA761074
    Listing Certified Through n/a

    Package

    NDC 67457-0847-44 (67457084744)

    NDC Package Code 67457-847-44
    Billing NDC 67457084744
    Package 1 KIT in 1 CARTON (67457-847-44) * 20 mL in 1 VIAL, MULTI-DOSE (67457-845-50) * 20 mL in 1 VIAL (67457-846-20)
    Marketing Start Date 2019-11-29
    NDC Exclude Flag N
    Pricing Information N/A